Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) shares, rose in value on Friday, July 11, with the stock price down by -1.50% to the previous day’s close as strong demand from buyers drove the stock to $14.43.
Actively observing the price movement in the last trading, the stock closed the session at $14.65, falling within a range of $14.17 and $14.73. The value of beta (5-year monthly) was 1.488. Referring to stock’s 52-week performance, its high was $19.09, and the low was $9.00. On the whole, CNTA has fluctuated by 19.06% over the past month.
With the market capitalization of Centessa Pharmaceuticals plc ADR currently standing at about $1.93 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-14.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CNTA’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of CNTA currently trading nearly 8.52% and 11.37% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 61.88, while the 7-day volatility ratio is showing 5.67% which for the 30-day chart, stands at 5.57%. Furthermore, Centessa Pharmaceuticals plc ADR (CNTA)’s beta value is 1.45.
A comparison of Centessa Pharmaceuticals plc ADR (CNTA) with its peers suggests the former has fared considerably weaker in the market. CNTA showed an intraday change of -1.50% in last session, and over the past year, it shrunk by -13.85%%.
Data on historical trading for Centessa Pharmaceuticals plc ADR (NASDAQ:CNTA) indicates that the trading volumes over the past 10 days have averaged 0.83 and over the past 3 months, they’ve averaged 883.54K. According to company’s latest data on outstanding shares, there are 133.55 million shares outstanding.
Nearly 36.55% of Centessa Pharmaceuticals plc ADR’s shares belong to company insiders and institutional investors own 57.62% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.47 million shares as on 2025-06-13, resulting in a short ratio of 4.45. According to the data, the short interest in Centessa Pharmaceuticals plc ADR (CNTA) stood at 394.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 5.52 million. The stock has risen by 47.40% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CNTA stock heading into the next quarter.
